10021Fifth meeting of the Vector Control Technical Expert Group (VCTEG): meeting report, 14-16 November 2017, Geneva, SwitzerlandTechnical Documents · 21 décembre 2017
10022Country health emergency preparedness and IHR: preparedness and core capacity building unit: WHO Lyon Office: advanced technical support to countries: activity report Oct.2016-Oct.2017Technical Documents · 21 décembre 2017
10023Summary report on the regional training workshop on sanitation/wastewater safety planning, Amman, Jordan, 24–27 July 2017Technical Documents · 20 décembre 2017
10024Report of the third WHO consultation on the Global Action Plan for Influenza Vaccines: Geneva, Switzerland, 15-16 November 2016Technical Documents · 20 décembre 2017
10025Joint external evaluation of IHR core capacities of the Republic of the Gambia: mission report, September 24-29, 2017Technical Documents · 19 décembre 2017
10026UHC Technical Brief: Strengthening health information systemsTechnical Documents · 19 décembre 2017
10027Evaluation externe conjointe des principales capacités RSI de la République du Tchad : résumé de mission, 7 au 12 août 2017Technical Documents · 19 décembre 2017
10028Models to inform fast tracking voluntary medical male circumcision in HIV combination prevention: meeting report, 23–24 March 2016Technical Documents · 18 décembre 2017
10029Achieving universal coverage through better water, sanitation and hygiene services in health care facilities: a focus on Cambodia and EthiopiaTechnical Documents · 15 décembre 2017
10030Joint external evaluation of IHR core capacities of the Kyrgyz Republic: mission report, 28 November - 2 December 2016Technical Documents · 15 décembre 2017
10031Ethical issues associated with vector-borne diseases: report of a WHO scoping meeting, Geneva, 23–24 February 2017Technical Documents · 14 décembre 2017
10032Development of a systematic evidence review for the WHO guideline on protecting workers from potential risks of manufactured nanomaterials: what training should be provided to workers who are at risk from exposure to the specific nanomaterials or groups of nanomaterials?Technical Documents · 14 décembre 2017
10033Безопасное управление отходами медико-санитарной деятельности: краткая информацияTechnical Documents · 14 décembre 2017
10034The investment case for non‐communicable disease prevention and control in BarbadosTechnical Documents · 14 décembre 2017
10035Systematic evidence review for developing WHO guidelines on protecting workers from potential risks of manufactured nanomaterials: which hazard category should specific nanomaterials or groups of nanomaterials be assigned to and how?Technical Documents · 14 décembre 2017
10036How to design vector control efficacy trials: guidance on phase III vector control field trial design provided by the Vector Control Advisory GroupTechnical Documents · 14 décembre 2017
10037Évaluation externe conjointe des principales capacités RSI de la République du Cameroun : rapport de mission, 25-29 septembre 2017Technical Documents · 13 décembre 2017
10038Joint external evaluation of IHR core capacities of the Republic of Zambia: mission report, 7-11 August 2017Technical Documents · 13 décembre 2017
10039Notification systems for shortages and stockouts of medicines and vaccines: technical consultation meeting report, July 2017Technical Documents · 12 décembre 2017
10040Antimicrobial resistance in the Eastern Mediterranean RegionTechnical Documents · 12 décembre 2017